Evoke Pharma Inc (EVOK)

03:04 AM

Evoke Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

03:04 AM

03:09 AM

Evoke Pharma Inc (EVOK) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans - Yahoo Canada Finance

03:09 AM

02:24 AM

Evoke Pharma Reports Strong Revenue Growth in 2024 - TipRanks

02:24 AM

Mar 13, 2025

Earnings call transcript: Evoke Pharma Q4 2024 reports strong sales growth - Investing.com

Mar 13, 2025

Mar 13, 2025

Evoke Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Marketscreener.com

Mar 13, 2025

Mar 13, 2025

EVOKE PHARMA Earnings Results: $EVOK Reports Quarterly Earnings - Nasdaq

Mar 13, 2025

Mar 13, 2025

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 13, 2025

Mar 13, 2025

The Canada Foundation for Innovation supports Canada Research Chairs with nearly $4.4 million investment in research infrastructure - The Manila Times

Mar 13, 2025

Mar 13, 2025

Earnings Scheduled For March 13, 2025 - Benzinga

Mar 13, 2025

Mar 12, 2025

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Mar 12, 2025

Mar 10, 2025

Gastroparesis Treatment Market Poised for Substantial Growth - openPR

Mar 10, 2025

Mar 06, 2025

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025 - GlobeNewswire

Mar 06, 2025

Mar 06, 2025

Evoke Pharma, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025 - Nasdaq

Mar 06, 2025

Mar 06, 2025

When Will Evoke Pharma Share Its Latest Gimoti Sales Numbers? - StockTitan

Mar 06, 2025

Mar 05, 2025

Evoke Pharma (EVOK) to Release Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025

Mar 04, 2025

Sanctuary Advisors LLC Sells 40,570 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) - Defense World

Mar 04, 2025

Mar 04, 2025

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Sold by Sanctuary Advisors LLC - Defense World

Mar 04, 2025

Mar 04, 2025

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sanctuary Advisors LLC - Defense World

Mar 04, 2025

Mar 04, 2025

Evoke Pharma (NASDAQ:EVOK) Stock Crosses Below 200 Day Moving Average – Should You Sell? - Defense World

Mar 04, 2025

Mar 04, 2025

Alliance Bioenergy Plus (OTCMKTS:ALLM) Shares Cross Below 200 Day Moving Average – Time to Sell? - Defense World

Mar 04, 2025

Mar 04, 2025

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Defense World

Mar 04, 2025

Mar 03, 2025

Evoke Pharma stock hits 52-week low at $3.49 amid challenges - Investing.com India

Mar 03, 2025

Mar 03, 2025

Evoke Pharma stock hits 52-week low at $3.49 amid challenges By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 01, 2025

Evoke Pharma, Inc. to Host Earnings Call - ACCESS Newswire

Mar 01, 2025

Feb 27, 2025

Investor Network: Evoke Pharma, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Gastroparesis Drugs Market Forecast: Insights, Trends & Key - openPR

Feb 27, 2025

Feb 26, 2025

Diabetic Gastroparesis Treatment Market Future Business - openPR

Feb 26, 2025

Feb 25, 2025

Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com - Armenian Reporter

Feb 25, 2025

Feb 24, 2025

Evoke Pharma adds pharma veteran to its board - Investing.com

Feb 24, 2025

Feb 24, 2025

Evoke Pharma adds pharma veteran to its board By Investing.com - Investing.com South Africa

Feb 24, 2025

Feb 24, 2025

Evoke Pharma appoints new director Greg Pyszcymuka - Investing.com

Feb 24, 2025

Feb 24, 2025

5 Top AI Stocks I'm Buying on the Dip - The Globe and Mail

Feb 24, 2025

Feb 24, 2025

Evoke Pharma appoints new director Greg Pyszcymuka By Investing.com - Investing.com South Africa

Feb 24, 2025

Feb 24, 2025

Evoke Pharma, Inc. Appoints Greg Pyszczymuka to Board of Directors, Strengthening Commercial Strategy - Nasdaq

Feb 24, 2025

Feb 24, 2025

Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors - GlobeNewswire

Feb 24, 2025

Feb 24, 2025

Can This New Board Member Transform Evoke Pharma's Commercial Success? - StockTitan

Feb 24, 2025

Feb 24, 2025

(EVOK) Investment Analysis and Advice - Stock Traders Daily

Feb 24, 2025

Feb 24, 2025

Geriatric Medicines Market Poised for Significant Expansion | - openPR

Feb 24, 2025

Feb 24, 2025

Gastric Motility Disorder Drug Market Witnessing High Demand | - openPR

Feb 24, 2025

Feb 24, 2025

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com - Defense World

Feb 24, 2025

Feb 21, 2025

Gastroparesis Drugs Market: $6,662.35 Million by 2032, 4.4% CAGR - openPR

Feb 21, 2025

Feb 17, 2025

Gastroparesis Treatment Market Generated Opportunities, - openPR

Feb 17, 2025

Feb 17, 2025

Evoke Pharma (NASDAQ:EVOK) Now Covered by StockNews.com - Defense World

Feb 17, 2025

Feb 14, 2025

Loss-Making Evoke Pharma, Inc. (NASDAQ:EVOK) Set To Breakeven - Simply Wall St

Feb 14, 2025

Feb 08, 2025

Research Analysts’ New Coverage for February 8th (AC, APT, ARL, BIOL, CCRN, CNET, EDAP, ENLC, ENSV, ESGR) - Armenian Reporter

Feb 08, 2025

Feb 06, 2025

Gastroparesis Market Expected to rise, 2034 | Vanda - openPR

Feb 06, 2025

Feb 04, 2025

Nantahala Capital Management, LLC Increases Stake in Evoke Pharm - GuruFocus.com

Feb 04, 2025

Jan 31, 2025

Evoke Pharma (NASDAQ:EVOK) Stock Crosses Below 200 Day Moving Average – Here’s What Happened - Defense World

Jan 31, 2025

Jan 31, 2025

StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Jan 31, 2025

Jan 30, 2025

Nantahala Capital Management, LLC Reduces Stake in Evoke Pharma Inc - GuruFocus.com

Jan 30, 2025

Jan 29, 2025

Trane Technologies (TT) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Jan 29, 2025

Jan 28, 2025

VF Corp (VFC) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Jan 28, 2025